Literature DB >> 21316546

[Exacerbation of chronic obstructive pulmonary disease].

Myriam Calle Rubio1, Beatriz Morales Chacón, Juan Luis Rodríguez Hermosa.   

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) are considered to be episodes of instability that favor disease progression, reduce quality of life, increase the risk of death and cause substantial healthcare resource use. These exacerbations are due to bacterial and viral infections and environmental stressors. However, other concomitant diseases such as heart disease, other lung diseases (e.g. pulmonary embolism, aspiration or pneumothorax) and other systemic processes can trigger or complicate these exacerbations. The two factors with the greatest influence on the physiopathology of exacerbations are dynamic overinflation and local and systemic inflammation. In most patients, drug treatment includes short-acting bronchodilators, systemic corticosteroids and antibiotics. Hypoxemic respiratory failure requires controlled oxygen therapy. In hypercapnic respiratory failure, non-invasive positive pressure ventilation may allow time to be gained until other treatments begin to take effect and can thus avoid endotracheal intubation. The use of non-invasive mechanical ventilation should never delay intubation, if indicated. Hospital discharge criteria are based on both clinical and gasometric stabilization and on the patient's ability to manage his or her disease at home. Hospitalization at home can be a treatment option in COPD exacerbations and is as effective as conventional hospitalization.
Copyright © 2010 Sociedad Española de Neumología y Cirugía Torácica. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21316546      PMCID: PMC7130601          DOI: 10.1016/S0300-2896(10)70042-9

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  12 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  [Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)].

Authors:  Germán Peces-Barba; Joan Albert Barberà; Alvar Agustí; Ciro Casanova; Alejandro Casas; José Luis Izquierdo; José Jardim; Victorina López Varela; Eduard Monsó; Teodoro Montemayor; José Luis Viejo
Journal:  Arch Bronconeumol       Date:  2008-05       Impact factor: 4.872

3.  [Antimicrobial treatment of exacerbation in chronic obstructive pulmonary disease: 2007 consensus statement].

Authors:  Marc Miravitlles; Eduard Monsó; José Mensa; Jesús Aguarón Pérez; José Barberán; Mario Bárcena Caamaño; José Luis Cañada Merino; Mikel Martínez Ortiz de Zárate; Manuel S Moya Mir; Juan J Picazo; José Antonio Quintano Jiménez; José Angel García-Rodríguez
Journal:  Arch Bronconeumol       Date:  2008-02       Impact factor: 4.872

4.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; E A Paul; J C Bestall; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

5.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Authors:  J J Soler-Cataluña; M A Martínez-García; P Román Sánchez; E Salcedo; M Navarro; R Ochando
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

Review 6.  Toward a consensus definition for COPD exacerbations.

Authors:  R Rodriguez-Roisin
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

7.  [The impact of COPD on hospital resources: the specific burden of COPD patients with high rates of hospitalization].

Authors:  J Soler; L Sánchez; M Latorre; J Alamar; P Román; M Perpiñá
Journal:  Arch Bronconeumol       Date:  2001-10       Impact factor: 4.872

Review 8.  Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature.

Authors:  Helen Doll; Marc Miravitlles
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

9.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; J Manfreda; C P Warren; E S Hershfield; G K Harding; N A Nelson
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

10.  Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Paul Hebert; Robert Dales; Ian G Stiell; Jan Ahuja; Garth Dickinson; Robert Brison; Brian H Rowe; Jonathan Dreyer; Elizabeth Yetisir; Daniel Cass; George Wells
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

View more
  2 in total

1.  Readmission Due to Exacerbation of COPD: Associated Factors.

Authors:  Alicia Cerezo Lajas; Enrique Gutiérrez González; César Llorente Parrado; Luis Puente Maestu; Javier de Miguel-Díez
Journal:  Lung       Date:  2018-02-14       Impact factor: 2.584

2.  A scoring system to detect fixed airflow limitation in smokers from simple easy-to-use parameters.

Authors:  Esther Román-Conejos; Antonio Palazón-Bru; David Manuel Folgado-de la Rosa; Manuel Sánchez-Molla; María Mercedes Rizo-Baeza; Vicente Francisco Gil-Guillén; Ernesto Cortés-Castell
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.